The Role of α3β1 Integrin Modulation on Fabry Disease Podocyte Injury and Kidney Impairment.
Bruna BosquettiAline Aparecida SantanaPaulo Cézar GregórioRegiane Stafim da CunhaGuilherme MiniskiskoskyJulia BudagCélia Regina Cavichiolo FrancoEdneia Amancio de Souza RamosFellype de Carvalho BarretoAndréa Emília Marques StinghenPublished in: Toxins (2023)
Podocyte dysfunction plays a crucial role in renal injury and is identified as a key contributor to proteinuria in Fabry disease (FD), primarily impacting glomerular filtration function (GFF). The α3β1 integrins are important for podocyte adhesion to the glomerular basement membrane, and disturbances in these integrins can lead to podocyte injury. Therefore, this study aimed to assess the effects of chloroquine (CQ) on podocytes, as this drug can be used to obtain an in vitro condition analogous to the FD. Murine podocytes were employed in our experiments. The results revealed a dose-dependent reduction in cell viability. CQ at a sub-lethal concentration (1.0 µg/mL) induced lysosomal accumulation significantly ( p < 0.0001). Morphological changes were evident through scanning electron microscopy and immunofluorescence, highlighting alterations in F-actin and nucleus morphology. No significant changes were observed in the gene expression of α3β1 integrins via RT-qPCR. Protein expression of α3 integrin was evaluated with Western Blotting and immunofluorescence, demonstrating its lower detection in podocytes exposed to CQ. Our findings propose a novel in vitro model for exploring secondary Fabry nephropathy, indicating a modulation of α3β1 integrin and morphological alterations in podocytes under the influence of CQ.
Keyphrases
- high glucose
- diabetic nephropathy
- endothelial cells
- electron microscopy
- gene expression
- cell migration
- replacement therapy
- hypertrophic cardiomyopathy
- cell adhesion
- dna methylation
- oxidative stress
- emergency department
- escherichia coli
- smoking cessation
- atrial fibrillation
- staphylococcus aureus
- real time pcr
- adverse drug
- electronic health record
- sensitive detection